BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29676715)

  • 1. [European Reference Networks for rare diseases].
    Vos JR; van Zelst-Stams WAG; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2018; 162():D2376. PubMed ID: 29676715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
    Vos JR; Giepmans L; Röhl C; Geverink N; Hoogerbrugge N;
    Fam Cancer; 2019 Apr; 18(2):281-284. PubMed ID: 30302652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [European Reference Networks : Consequences for healthcare in Germany].
    Graessner H; Schäfer F; Scarpa M; Wagner TOF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Reference Networks and Guideline Development and Use: Challenges and Opportunities.
    Morciano C; Laricchiuta P; Taruscio D; Schünemann H
    Public Health Genomics; 2015; 18(5):318-20. PubMed ID: 26227062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)].
    Schulz L; Sebode M; Schramm C; Lohse AW
    Internist (Berl); 2021 Apr; 62(4):441-448. PubMed ID: 33687527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Reference networks for rare diseases: what is the conceptual framework?
    Héon-Klin V
    Orphanet J Rare Dis; 2017 Aug; 12(1):137. PubMed ID: 28784158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RarERN Path: a methodology towards the optimisation of patients' care pathways in rare and complex diseases developed within the European Reference Networks.
    Talarico R; Cannizzo S; Lorenzoni V; Marinello D; Palla I; Pirri S; Ticciati S; Trieste L; Triulzi I; Terol E; Bucher A; Turchetti G
    Orphanet J Rare Dis; 2020 Dec; 15(1):347. PubMed ID: 33317578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position statement on the role of healthcare professionals, patient organizations and industry in European Reference Networks.
    Hollak CE; Biegstraaten M; Baumgartner MR; Belmatoug N; Bembi B; Bosch A; Brouwers M; Dekker H; Dobbelaere D; Engelen M; Groenendijk MC; Lachmann R; Langendonk JG; Langeveld M; Linthorst G; Morava E; Poll-The BT; Rahman S; Rubio-Gozalbo ME; Spiekerkoetter U; Treacy E; Wanders R; Zschocke J; Hagendijk R
    Orphanet J Rare Dis; 2016 Jan; 11():7. PubMed ID: 26809514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
    Mathoulin-Pélissier S; Pritchard-Jones K
    Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving treatment results with reference centres for rare cancers: where do we stand?
    Ray-Coquard I; Pujade Lauraine E; Le Cesne A; Pautier P; Vacher Lavenue MC; Trama A; Casali P; Coindre JM; Blay JY
    Eur J Cancer; 2017 May; 77():90-98. PubMed ID: 28384534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Healthcare networks for people with rare diseases: integrating data and expertise].
    Graessner H; Storf H; Schaefer F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.
    Talarico R; Aguilera S; Alexander T; Amoura Z; Andersen J; Arnaud L; Avcin T; Marsal Barril S; Beretta L; Bombardieri S; Bortoluzzi A; Bouillot C; Bulina I; Burmester GR; Cannizzo S; Cavagna L; Chaigne B; Cornet A; Corti P; Costedoat-Chalumeau N; Dāvidsone Z; Doria A; Fenech C; Ferraris A; Fischer-Betz R; Fonseca JE; Frank C; Gaglioti A; Galetti I; Guimarães V; Hachulla E; Holmner M; Houssiau F; Iaccarino L; Jacobsen S; Limper M; Malfait F; Mariette X; Marinello D; Martin T; Matthews L; Matucci-Cerinic M; Meyer A; Milas-Ahić J; Moinzadeh P; Montecucco C; Mouthon L; Müller-Ladner U; Nagy G; Patarata E; Pileckyte M; Pruunsild C; Rednic S; Romão VC; Schneider M; Scirè CA; Smith V; Sulli A; Tamirou F; Tani C; Taruscio D; Taulaigo AV; Tincani A; Ticciati S; Turchetti G; van Hagen PM; van Laar JM; Viera A; de Vries-Bouwstra JK; Zschocke J; Cutolo M; Mosca M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):3-11. PubMed ID: 35349419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The actual questions of the care of rare diseases].
    Pogány G
    Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wide disparity of clinical genetics services and EU rare disease research funding across Europe.
    Lynch SA; Borg I
    J Community Genet; 2016 Apr; 7(2):119-26. PubMed ID: 26536881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium.
    Stordeur S; Vrijens F; Leroy R
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):1-6. PubMed ID: 26745998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of EXABO - An Expert Advisory Board for the European Reference Network for Rare Respiratory Diseases.
    Walther D; Steinmann O; Wagner TOF; Storf H
    Stud Health Technol Inform; 2020 Jun; 270():986-990. PubMed ID: 32570529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.